Navigation Links
AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test
Date:7/14/2008

e significantly higher across all types of gastrointestinal cancers tested and not limited to specific tumor types, suggesting the AMDL-ELISA DR-70 (FDP) test could be clinically used as a global cancer detection tool.

According to the results:

-- The AMDL-ELISA DR-70 (FDP) test showed strong clinical performance

with a sensitivity of 91% and a specificity of 93% in testing

conducted on patients with hepatocellular, cholangiocellular,

pancreatic, colorectal, stomach and oesophagus cancers.

-- The test reliably differs between patients with cancer of the

gastrointestinal tract or the hepatobilary system and healthy

patients; therefore showing promise as a useful cancer detection tool

in clinical practice.

-- The study also found an association between the quantitative DR-70

value and the stage of the cancer in patients tested which suggests

the AMDL-ELISA DR-70 (FDP) test can also be used as a prognostic

factor in cancer monitoring.

About AMDL: Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The AMDL ELISA DR-70 (FDP) cancer diagnostic test was cleared to market by the US FDA on July 13, 2008 and the Company has 4 additional pharmaceutical and diagnostic products under review by various regulatory authorities. For additional information on AMDL and its products visit the company's website at http://www.amdl.com or call +1 (714)505-4460.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations<
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
2. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
3. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
4. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
5. Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
6. Promising Data ATIR Studies Presented by NIH Investigators
7. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
8. Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction
9. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
10. Mega-Brand Success: Effective Market Strategy and Tactics
11. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Global Stem ... announced plans for the company’s first cellular and regenerative ... by a full day, hands-on stem cell training class ... Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA) ... community’s increasing interest in regenerative medicine and recent advances ...
(Date:5/26/2015)... FORT WORTH, Texas , May 26, 2015 /PRNewswire-USNewswire/ ... North Texas Health Science Center to detect early Alzheimer,s ... screen older adults. Detailed standardized guidelines that ... in practice have been published in Alzheimer,s & ... continued efforts of an international working group that includes ...
(Date:5/26/2015)... , 26. mája 2015 ... mene svojej rodiny prezidentom Barackovi Obamovi a Billovi ... súvislosti so stratou Dr. Rongxiang Xu , ... http://photos.prnewswire.com/prnh/20150522/218111 Dr. Xu bol pionier, ... a jeho odhodlanie v oblasti vedy a príkladné ...
(Date:5/26/2015)... JERUSALEM , May 26, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has submitted the study protocol for the company,s ... to the U.S. Food and Drug Administration (FDA). The ... Drug (IND) application. The Phase IIb study ...
Breaking Biology Technology:Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2Dr. Rongxiang Xu, O legende 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") (Nasdaq: CMED ... markets advanced in-vitro diagnostic,products, today announced that it will attend ... to October 31, 2009 in Chengdu,China. , , ... 62nd China International Medical Equipment Fair, Date: ...
... a failed terrorist attack in 2006, plane passengers have not ... airports, leaving some parched at the airport and others having ... in Germany is paving the way to eliminate this necessary ... in IOP Publishing,s Superconductor Science and Technology explains ...
... SAN DIEGO, Oct. 20 NuVasive, Inc. ... developing products for minimally disruptive surgical treatments for the spine, ... 2009. , NuVasive reported third quarter revenue of $94.9 million, ... quarter 2008 and a 7.3% increase over the $88.5 million ...
Cached Biology Technology:China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China 20.2 second test for explosive liquids 2NuVasive Reports Third Quarter 2009 Financial Results 2NuVasive Reports Third Quarter 2009 Financial Results 3NuVasive Reports Third Quarter 2009 Financial Results 4NuVasive Reports Third Quarter 2009 Financial Results 5NuVasive Reports Third Quarter 2009 Financial Results 6NuVasive Reports Third Quarter 2009 Financial Results 7NuVasive Reports Third Quarter 2009 Financial Results 8NuVasive Reports Third Quarter 2009 Financial Results 9NuVasive Reports Third Quarter 2009 Financial Results 10NuVasive Reports Third Quarter 2009 Financial Results 11NuVasive Reports Third Quarter 2009 Financial Results 12
(Date:5/14/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ... Sensors Market in Smart Mobile Devices " report ... 2014 was a watershed year for fingerprint sensors in ... Pay,. Apple gave fingerprint sensors a raison d,etre in ... sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)...  Through a well-rounded UAS delegation representing private industry, government, ... showing at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people ... the UAS ecosystem. "Our message is clear ... Aerospace Rich Knoll . "If you want to fly ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
... to visualize more of the arteries in the lungs, ... seeing more may have little impact on the patient's ... 198 patients with suspected pulmonary embolism. About half of ... 100 patients had a single-detector CT examination. The radiology ...
... process that repairs damage to the human genome, ... helped establish a method of gene therapy that ... genes. , The findings are available online in ... process known as homologous recombination, Dr. Matthew Porteus ...
... countries of sub-Saharan Africa are threatened daily by a ... disease is caused by organisms called trypanosomes, which are ... approximately 500,000 people in sub-Saharan Africa, a quarter of ... an exceptional genetic strategy for evading the human immune ...
Cached Biology News:Newer imaging techniques may lead to over-treatment 2Researchers pioneer new gene therapy technique using natural repair process 2Researchers pioneer new gene therapy technique using natural repair process 3Breakthrough System for Understanding Ocean Plant Life Announced 2
I-Ab MHC Class II...
... 60 mm Culture Dishes BD BioCoat Collagen ... with a uniform application of rat tail collagen ... I ,Surface : ECM/attachment factors ... nominal : 60 mm x 15 mm ...
The piston kit includes 2 pistons to service one F10 pump of a BioLogic DuoFlow workstation....
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
Biology Products: